Products are for sold for Research Only and no other use.

High Purity

Laboratory Tested

Secure Payments

Bank Transfer & More

Delivery

UK & Europe Wide

Semaglutide Atomiser

Semaglutide Atomiser

£75.00

Semaglutide: Revolutionary GLP-1 Receptor Agonist for Metabolic Research

Overview: Semaglutide stands at the forefront of metabolic disease research, heralding a new era in the management and understanding of diabetes and obesity. This innovative glucagon-like peptide-1 (GLP-1) receptor agonist has been meticulously engineered to mimic the natural gut hormone that lowers blood sugar levels post-meal. Available as a lyophilized powder for research purposes, Semaglutide offers unparalleled opportunities for in-depth study into metabolic disorders, showcasing potent glucose-lowering effects along with a promising potential to address obesity.

Category

Secure Payment

High Purity

Fast Delivery

  • Description
  • Additional Information
Semaglutide: Revolutionary GLP-1 Receptor Agonist for Metabolic Research Overview: Semaglutide stands at the forefront of metabolic disease research, heralding a new era in the management and understanding of diabetes and obesity. This innovative glucagon-like peptide-1 (GLP-1) receptor agonist has been meticulously engineered to mimic the natural gut hormone that lowers blood sugar levels post-meal. Available as a lyophilized powder for research purposes, Semaglutide offers unparalleled opportunities for in-depth study into metabolic disorders, showcasing potent glucose-lowering effects along with a promising potential to address obesity. Key Features:
  • Molecular Fidelity: Semaglutide mirrors the physiological effects of endogenous GLP-1, engaging the GLP-1 receptor with high affinity. This similarity provides a robust model for studying the intricate mechanisms underlying glucose homeostasis and appetite regulation.
  • Extended Half-Life: Engineered for enhanced stability, Semaglutide exhibits an extended half-life, enabling less frequent dosing schedules in research models compared to naturally occurring GLP-1. This property is vital for longitudinal studies aiming to assess long-term therapeutic outcomes.
  • Versatile Application: Its application extends beyond diabetes to encompass obesity research, offering a dual-action approach to explore treatments that modulate blood sugar levels and reduce body weight. Semaglutide's ability to decrease appetite and food intake makes it an invaluable tool for studying the neuroendocrine pathways involved in energy balance and metabolism.
  • Purity and Potency: Supplied as a high-purity, lyophilized powder, Semaglutide ensures reproducibility and precision in experimental setups. Each batch undergoes stringent quality control measures to guarantee its activity and consistency, facilitating reliable results across various research scenarios.